AU5358300A - Sunscreen compositions - Google Patents
Sunscreen compositions Download PDFInfo
- Publication number
- AU5358300A AU5358300A AU53583/00A AU5358300A AU5358300A AU 5358300 A AU5358300 A AU 5358300A AU 53583/00 A AU53583/00 A AU 53583/00A AU 5358300 A AU5358300 A AU 5358300A AU 5358300 A AU5358300 A AU 5358300A
- Authority
- AU
- Australia
- Prior art keywords
- sunscreen
- composition according
- sunscreen composition
- agent
- titanium dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 185
- 239000000516 sunscreening agent Substances 0.000 title claims description 116
- 230000000475 sunscreen effect Effects 0.000 title claims description 92
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 133
- 239000004408 titanium dioxide Substances 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- -1 alkyl sulfosuccinates Chemical class 0.000 claims description 35
- 239000003921 oil Substances 0.000 claims description 34
- 239000008367 deionised water Substances 0.000 claims description 25
- 229910021641 deionized water Inorganic materials 0.000 claims description 25
- 239000003995 emulsifying agent Substances 0.000 claims description 21
- 239000002199 base oil Substances 0.000 claims description 19
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000012874 anionic emulsifier Substances 0.000 claims description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000003974 emollient agent Substances 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 230000037072 sun protection Effects 0.000 claims description 8
- 239000011787 zinc oxide Substances 0.000 claims description 8
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000077 insect repellent Substances 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 235000010233 benzoic acid Nutrition 0.000 claims description 4
- 230000000052 comparative effect Effects 0.000 claims description 4
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000570 polyether Polymers 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 125000005480 straight-chain fatty acid group Chemical class 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 230000035614 depigmentation Effects 0.000 claims description 3
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 claims description 3
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 235000021317 phosphate Nutrition 0.000 claims description 2
- 239000011164 primary particle Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims 2
- OKTJSMMVPCPJKN-YPZZEJLDSA-N carbon-10 atom Chemical group [10C] OKTJSMMVPCPJKN-YPZZEJLDSA-N 0.000 claims 1
- 235000010215 titanium dioxide Nutrition 0.000 description 62
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 235000021355 Stearic acid Nutrition 0.000 description 34
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 34
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 34
- 239000008117 stearic acid Substances 0.000 description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 30
- 239000012071 phase Substances 0.000 description 30
- 238000009472 formulation Methods 0.000 description 25
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 19
- 239000002253 acid Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- 239000000047 product Substances 0.000 description 18
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 16
- 229910052708 sodium Inorganic materials 0.000 description 16
- 239000011734 sodium Substances 0.000 description 16
- 235000011187 glycerol Nutrition 0.000 description 15
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 15
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 14
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 14
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 14
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 13
- 229940081733 cetearyl alcohol Drugs 0.000 description 13
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 229910052938 sodium sulfate Inorganic materials 0.000 description 13
- 235000011152 sodium sulphate Nutrition 0.000 description 13
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 12
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 12
- 229940036350 bisabolol Drugs 0.000 description 12
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 9
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 9
- UKHVLWKBNNSRRR-ODZAUARKSA-M dowicil 200 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C\C=C/Cl)C3 UKHVLWKBNNSRRR-ODZAUARKSA-M 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000005855 radiation Effects 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 125000000129 anionic group Chemical group 0.000 description 8
- 239000002480 mineral oil Substances 0.000 description 8
- 235000010446 mineral oil Nutrition 0.000 description 8
- 229960000541 cetyl alcohol Drugs 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- RMFFCSRJWUBPBJ-UHFFFAOYSA-N 15-hydroxypentadecyl benzoate Chemical compound OCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RMFFCSRJWUBPBJ-UHFFFAOYSA-N 0.000 description 6
- 101100388212 Arabidopsis thaliana DSP3 gene Proteins 0.000 description 6
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 6
- 229950001798 amiphenazole Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 235000020944 retinol Nutrition 0.000 description 5
- 239000011607 retinol Substances 0.000 description 5
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 4
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 4
- 150000007942 carboxylates Chemical class 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 3
- OJDYHYHPMJTDEQ-UHFFFAOYSA-N 2-[1-(2-hexyldodecoxy)propan-2-yloxy]ethyl acetate Chemical compound CCCCCCCCCCC(CCCCCC)COCC(C)OCCOC(C)=O OJDYHYHPMJTDEQ-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 229910010413 TiO 2 Inorganic materials 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940009662 edetate Drugs 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 235000013980 iron oxide Nutrition 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000020945 retinal Nutrition 0.000 description 2
- 239000011604 retinal Substances 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 2
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 238000004078 waterproofing Methods 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LDQYRCPDQDZUOY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)propan-1-ol Chemical compound CCCCCCCCCCCCOCCOC(C)CO LDQYRCPDQDZUOY-UHFFFAOYSA-N 0.000 description 1
- GLGQRQQFWLTGES-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCOCCOCCOCCOCCOCCOCCO GLGQRQQFWLTGES-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- SBBKXEILGIUOKW-UHFFFAOYSA-N C(C)(=O)N.C1(O)=CC=C(O)C=C1 Chemical compound C(C)(=O)N.C1(O)=CC=C(O)C=C1 SBBKXEILGIUOKW-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JSFALRHXWSCNLF-UHFFFAOYSA-N [O-2].[O-2].[Ti+4].OC(C(C)=O)O Chemical compound [O-2].[O-2].[Ti+4].OC(C(C)=O)O JSFALRHXWSCNLF-UHFFFAOYSA-N 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000007780 powder milling Methods 0.000 description 1
- 229940095014 ppg 12 buteth 16 Drugs 0.000 description 1
- 229940037640 ppg-1-peg-9 lauryl glycol ether Drugs 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940096792 quaternium-15 Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- WKICFFQFXLKDIK-UHFFFAOYSA-M sodium;octadecanoate;propane-1,2-diol Chemical compound [Na+].CC(O)CO.CCCCCCCCCCCCCCCCCC([O-])=O WKICFFQFXLKDIK-UHFFFAOYSA-M 0.000 description 1
- CAKFJMXZPVHFCI-UHFFFAOYSA-M sodium;phenylmethanol;hydroxide Chemical class [OH-].[Na+].OCC1=CC=CC=C1 CAKFJMXZPVHFCI-UHFFFAOYSA-M 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
-1-
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT
ORIGINAL
Name of Applicant: Johnson Johnson Consumer Companies, Inc.
Actual Inventors: Elvin R. Lukenbach, Prakash Naik-Satam, Ralph Stutzman and Jean Holland.
Address for Service: BALDWIN SHELSTON WATERS MARGARET STREET SYDNEY NSW 2000 Invention Title: 'SUNSCREEN COMPOSITIONS' Details of Original Application No. 65409/96 dated 07 Jun 1996 The following statement is a full description of this invention, including the best method of performing it known to me/us:- File: 29227AUP00 1A- SUNSCREEN COMPOSITIONS Related Applications This application is a continuation-in-part of U.S.
Serial No. 08/495734, filed June 8, 1995, and hereby incorporates by reference that application and the subject matter therein into this application.
Field of the Invention 10 This invention relates to new and useful ultraviolet radiation sunscreen agents and compositions displaying enhanced protection and to methods of protecting human skin against the potentially harmful effects of sunlight.
Background of the Invention Although a tan has long been considered a status symbol indicative of good health *and the ability to secure sufficient leisure time to enjoy outdoor activities such as swimming, tennis, golf, skiing and the like, it has become very evident that excessive exposure of the human skin to sunlight is harmful.
It is well documented that human skin is sensitive to sunlight and artificial light containing radiation'of wavelengths between about 290 nanometers (nm) and 400 nm. Ultraviolet radiation of wavelengths between about 290 nm and 320 nm (UV-B region) has been known to rapidly produce damaging effects on the skin including reddening or erythema, edema, blistering or other skin eruptions in more severe cases. Prolonged or chronic 2 exposure to radiation in this wavelength range has been associated with serious skin conditions such as actinic keratoses and carcinomas. In recent years, concern has also been expressed regarding ultraviolet radiation of wavelengths above 320 nm (UV-A region) and the adverse effects of such radiation on human skin. The radiztion between 320 and 400 nm also contributes to the premature aging of-the skin. In addition, recent studies indicate that chronic sun exposure limits the immuno-response of 10 the skin. There is also evidence that a tan will offer some protection against burning but is quite ineffectual against other types of solar damage.
"Growing public awareness that the enjoyment of o outdoor activities must go hand in hand with adequate sun protection has led to an unprecedented growth in the area of sunscreen products. A desirable sunscreen product should have the following attributes: protection in both the UV-A and UV-B ultraviolet radiation ranges; maintenance of coverage, waterproof and perspiration proof; application and use convenience, ease of application, invisibility, non-staining and non-greasy; and freedom from irritation as a result of its ingredients, in particular, its active sunscreen ingredients. Of recent interest in this area have been some concerns over the irritancy and sensitization problems that may occur in some individuals utilizing sunscreen products with high SPF values containing organic sunscreen agents.
The effectiveness of a sunscreen product is indicated by its sun protection factor (SPF). The sun protection factor is the ratio of the amount of exposure -3 (dose) required to produce a minimal erythema reaction in protected skin to the amount required to produce the same reaction in unprotected skin. The absolute dose differs from person to person and is largely dependent on one's genetic predisposition and ethnic origin. If a person would normally require ten minute exposure to sunlight to develop a minimal erythema reaction, this person when using an SPF 15 sunscreen product should be able to tolerate up to 150 minutes of sunlight before developing a minimal erythema. Recent public awareness of the problems of exposure to sunlight has led to a demand for sunscreen products with high SPF values, at or above SPF 8.
Ease of application and cosmetic appeal, on the other hand, are important in formulating sunscreen compositions. These characteristics rely on subjective evaluations such as visual and tactile impression by the user. Consumer research studies indicate that a sunscreen formulation should rub in easily, leave the 20 skin non-sticky and, above all, should be invisible on the skin after application. Sunscreen compositions containing organic sunscreen agents have been found, in .some cases, to be irritating to the skin. Therefore, use has been made of inorganic sunscreen agents, such as titanium dioxide and zinc oxide.
For example, Japanese Patent Application No. 1981 161,881, describes cosmetics containing 0.1-40% of ultrafine divided titanium oxide with a particle size of 10-30 nanometers (nm) which has been rendered hydrophobic. It indicates that when hydrophobically treated titanium oxide with a particle size of 10-30 nm 4 is blended into cosmetic base materials, it transmits visible light but reflects and scatters the harmful ultraviolet rays. It has been found that when these titanium dioxide compositions are utilized as a sunscreen agent in sunscreen compositions, it may result in the loss of one of the most desired properties of such compositions, invisibility.
U. S. Patent 5,028,417, issued July 2, 1991, describes sunscreen compositions containing microfine titanium dioxide. The particle size of the titanium dioxide is required to be less than 10 rm. It also states that other sunscreen agents can be utilized with the titanium dioxide.
U.S. Patent 5,340,567, issued 8/23/94 describes a sunscreen composition comprising a synergistic combination of titanium dioxide having a particle size of less than about 35 nm and zinc oxide having a particle size of less than about 50 nm with titanium dioxide and zinc oxide being present at given ratios.
German Patent 2?o. 3,642,794 (1987) describes a cosmetic composition for preventing sunburn which contains 1-25% zinc oxide of a particle size of 70-300 microns. It further indicates that the composition may also contain titanium dioxide of a particle size of 30-70 microns. This composition is undesirable due to its unaesthetic whiteness characteristics at high SPF levels.
U. S. Patent 5,188,831, issued February 23, 1993, describes sunscreen compositions wherein the sunscreen effect is obtained from a blend of oil-dispersible ultrafine titanium dioxide and water-dispersible 5 titanium dioxide. However, the SPF level obtained is only of 10 with a total concentration of titanium dioxide of 5.0% w/w.
World Patent Application WO 90/06103, published June 14, 1990, describes titanium dioxide sunscreens where the microfine titanium dioxide particles are coated with a phospholipid, either through the use of a powder mill or through the making of a dispersion in an oil phase containing the phospholipid with a high shear.
10 mixer. The phospholipid coated titanium dioxide is then incorporated into sunscreen compositions. A high efficiency is claimed: the data presented shows SPF values of up to 11 for a 3.75% titanium dioxide concentration and up to 25 for a 7.5% concentration of titanium dioxide. The use of high shear mixer or a powder mill is a complicated and energy intensive process.
EP 535972 Al, published 04/07/93 describes a method of preparing sunscreens in which a dispersion of zinc 20 oxide and/or titanium dioxide particles in an oil is formed by milling.
EP 619999 A2, published 10/19/94 describes an.
aqueous dispersion of particulate metallic oxide of particle size less than 200 nm mixed with an emulsifier and an oil phase and also an organic hydrophobic sunscreen to form an o/w emulsion. The resulting sun protection composition has a higher SPF than would be expected if there was only an additive effect. However, the titanium dioxide alone at 4% yielded a SPF of only 7 to about 11.
6 EP 628303, published 10/19/94 describes a process for preparing a sunscreen composition. It consists of mixing sunscreen particles of metallic oxide less than 200 nm dispersed in an oil with one or more emulsifier and/or organic sunscreens. The resulting sunscreen composition is claimed to have a SPF value considerably higher than expected. The high SPF is only obtained when a metallic oxide is blended with an organic sunscreen. In fact, when no organic sunscreen is used, 10 the SPF value is only about 7.
WO 93/11742 describes sunscreen compositions comprising titanium dioxide and iron oxide of particle.
I: size less than 200 nm preferably coated with a phospholipid.
An article published in DCI in September 1992 by Tioxide Specialties Ltd. describes various ways of incorporating oil or water dispersions of titanium dioxide in emulsions. However, no data is given on the resulting SPF values.
An article published in Cosmetics and Toiletries, Vol. 107, October 1992, describes various ways of formulating with a physical sunblock. The discussion focuses on using titanium dioxide in a dispersion or using an emulsifier which is also an effective dispersing agent for titanium dioxide. It states that SPF's far above 20 can be achieved. However, no examples are given, nor does the article mention the specific sunscreen components or their compositions.
A brochure published by the Tioxide Company on March 15, 1994, discloses inorganic sunscreens of high SPF values obtained without the addition of any organic -7sunscreens. When measured, the SPF of the sunscreen compositions was indeed that described. However, when the titanium dioxide concentration was measured, it was at least twice what was claimed.
U.S. Patent 5,498,406 describes sunscreen compositions in an oil-in-water emulsion containing both organic and inorganic sunscreens and comprising long chain
(C
25 45) alcohols for stabilization of the emulsion. This composition relies predominantly on the organic sunscreen actives. While the authors mention the use of stearic acid as a part of the oil in water composition, they teach against the use of stearic acid in stabilizing the titanium dioxide without C 2 2 4 alcohols.
10 A sunscreen was marketed in the late 1980's under the trademark SUNDOWN®, which contained both organic and inorganic sunscreen ingredients. In addition, it contained Velsan D8P3 and isostearic acid. However, it was not an efficient sunscreen, despite the addition of both organic and inorganic sunscreen ingredients.
OBJECTS OF THE INVENTION S° 15 It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative.
SUMMARY OF THE INVENTION According to a first aspect, the invention provides a sunscreen composition comprising: an inorganic sunscreen agent; an anionic emulsifier selected from the group consisting of salts of saturated fatty acids, salts of straight-chain fatty acids, alkyl sulfosuccinates, alkyl phosphates and mixtures thereof; and 8an oil component comprising a carrier oil and at least one emollient.
According to a second aspect, the invention provides a method of making a sunscreen composition comprising: adding deionized water to a vessel; then, heating the water; then, adding a carrier oil and an anionic surfactant to the vessel; then, slowly adding an inorganic sunscreen agent to said vessel and heating and mixing said resultant composition; and then, adjusting the pH of said composition to above Unless the context clearly requires otherwise, throughout the description and the claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to".
More particularly, the present invention relates to sunscreen compositions s15 containing titanium dioxide and, optionally, zinc oxide of preferred particle size ranges, and'in preferred amount and ratios as the sunscreen agents.
These specific compositions permit the use of much lower amounts of the sunscreen active ingredients than previously achievable while still achieving the desired high SPF values for the compositions and without the unsightly whiteness which occurs in prior sunscreen compositions at concentrations above about In the sunscreen compositions of this invention, considerably higher concentrations of titanium dioxide may be used without incurring a whitening effect, even up to 15% with acceptable appearance, or possibly higher.
-9- Furthermore, our invention does not rely upon the use of hydrophilic titanium dioxide preparations as' required in the above noted patent, nor are energy intensive processes such as powder milling, nor are organic sunscreens actives required for the high efficacy.
The compositions of this invention provide sunscreen formulations having an SPF of at least 10 with a concentration level of titanium dioxide of about The compositions- of this invention exhibit extremely efficient uses of sunscreen components, particularly titanium dioxide. The compositions of this invention therefore may be formulated so as to contain relatively smaller amounts of titanium dioxide than used heretofore at a given SPF level.
Essentially, the compositions of this invention are easily made by simple mixing and provide an excellent dispersion of the inorganic sunscreen agent throughout the composition, thus ensuring even skin coverage. They are substantially invisible upon application to the skin.
15 DETAILED DESCRIPTION OF THE INVENTION The sunscreen compositions of this invention yield highly effective ultraviolet- (UV) blocking 10 capsoilities; that is, a given level of protection is provided with a significantly lower concentration of titanium dioxide than previously obtained using commercially available powdered titanium dioxides. They do not require the unusual processing methods previously necessary to disperse the titanium dioxide into an oil, such as preparation of sub-batch mill bases, high shear mixing or milling, or applying such milling procedures to the final product formulation. Typical titanium 0 dioxide sunscreen compositions of- SPF 15 require levels of titanium dioxide that impart a significant whitening effect to the skin; the compositions of this invention, minimize this disadvantage.
The compositions of this invention are oil-in-water 15 emulsions that are cosmetically superior to conventional inorganic sunscreen preparations, including water-in-oil titanium dioxide-only formulations, at equivalent
SPF
ratings, due to the low levels of titanium dioxide needed in the invention system. The compositions of 20 this invention can be used for sun protection in daily wear or facial products as well as recreational situations. Because of the efficiency of the system, the: inventive formulations are significantly lower in cost than other sunscreen systems.
There are several ingredients that contribute to the unexpectedly high efficiency of the compositions' blocking of UV radiation. These elements include the following materials: The compositions of this invention should include one or more of a select group of anionic emulsifiers.
In particular, salts of certain fatty acids are useful 11 in the formulations of this invention, preferably salts of saturated fatty acids and/or salts of straight-chain fatty acids. Alkali metal salts, alkali earth metal salts and amine salts are more preferable for use in the compositions of this invention. For example, stearic acid and its salts are useful as emulsifiers in the compositions of this invention, while the use of isostearate salts tends to produce a composition which is not very efficient in the use of sunscreen.
10 Likewise, oleate salts are not useful as they are unsaturated and do not result in efficient sunscreen compositions.
More particularly, the following anionic emulsifiers are useful in the compositions of this 15 invention: sodium stearate,.. sodium lauryl sulfate, DEA cetyl phosphate, sodium dioctyl sulfosuccinate and the like. Most preferably, the emulsifier should be sodium *stearate. While it is not fully understood why some *salts of fatty acids result in an inventive composition, it is theorized that salts of straight-chain fatty acids, (the fatty acids having a relatively high melting S" point, above 70 0 C or higher), are preferred due to their structure. For example, salts of branched or unsaturated fatty acids are not acceptable for use in the compositions of this invention.
The anionic emulsifiers should be present in the compositions of this invention in an amount from about 0.01 to about 10%, more preferably 0.1 to about 7% and most preferably from about 0.5 to about There may be additional emulsifiers present in the compositions of this invention, such as nonionic emulsifiers known to 12 those of ordinary sk±i. in the art, such as sorbitan esters and ethoxyiated sorbitan esters, ethoxylated fatty acids, fatty alcohols and ethoxylated fatty alcohols, fatty glyceride esters and ethoxylated fatty glyceride esters and the like. However, there should be at least one anionic emulsifier present in order to achieve the products of this invention. The fatty acid salt emulsifiers may be added to the composition as the salt, or the salt may be formed in situ.
10 A carrier oil should also be present in the compositions of this invention. It may be selected from the group of benzoic acid fatty alcohol esters, alkoxylated fatty alcohols and polyether interrupted fatty acid esters. The benzoic acid fatty alcohol esters described are commercially available under the trade name Finsolv, e.g. Finsolv TN, available from Finetex. The alkoxylated fatty alcohols are available under a variety of souzces such as Eumulgin L and Eumulgin B2 from Henkel, Sandoxylates from Clariant, 20 Marlox FK86 from Huls America, Procetyl AWS from Croda Chemicals and others.
Preferably, such carrier oils should be selected from the group of polyether interrupted fatty acid esters. More preferably, the carrier oil should be a Ce to C 22 fatty alkyl (optionally polypropylenoxy) polyethylenoxy carboxylate ester, the ester having an alkyl group which has from one to twenty-two carbon atoms, optionally straight or branched or can contain a phenyl group. Most preferably, the carrier oil should be a isopropyl PPG-2 isodeceth-7 carboxylate, such as Velsan D8P3 or other commercially available materials 13 sold by Clariant under the Velsan trade name. Other similar structures include Hetester PHA available from Bernel.
Preferably, the carrier oil should be present in the composition in an amount of between about 0.1% and about 10%. More preferably, it should be present in the amount of between about 1% and about Most preferably, it should be present in the amount of between about 2% and about 3%.
Preferably, the oil phase should contain at least two materials, the carrier oil and a conventional emollient known to those of ordinary skill in the art as useful in sunscreen products, such as mineral oil, ester oils, vegetable oils, silicones, synthetic emollients such as fatty acid esters and the like. This emollient should be present in the formulation in a ratio to the carrier concentration of from about 1:1 to about 3:1, most preferably, about 2:1. The carrier oil and the emollient should compose from about 2% to about 20% of the composition by weight.
The third element which should be present in the compositions of this invention is an inorganic sunscreen compound, such as titanium dioxide, zinc oxide or combinations thereof. Preferably, titanium dioxide should be used having a primary particle size from of less than about 300 nm in diameter. It should be present in the composition in the amount of from about 2% to about 25%. More preferably, it should be present in the amount of from about 2% to about 15%. Most preferably, it should be present in the amount of from about 3% to about 10%. The inorganic sunscreen compound 14 should be oil dispersible, and may be present with or without surface coating.
The ratio of titanium dioxide to the weight of the carrier oil and the emollient combined should be from about 0.3:1 to about 1:1. Most preferably, the ratio should be between about 0.5:1 and 2:3. For example, a composition containing 15% titanium dioxide, 8.33% Velsan D8P3, 12.5% Miglyol 812 and the remainder of the composition identical to that of Example 1 below, 10 results in a sunscreen composition having an SPF of 43.
The whiteness value of this composition is acceptable and is only slightly whitening on the skin.
In the case where salts of fatty acids are used care should be taken to keep the pH of the compositions of this invention at a level above about 5, more preferably, above about 5.5. Maintaining the pH at this level will ensure that these anionic emulsifiers remain in the salt form, which is important in retaining the stability and efficacy of the composition. When the 20 other listed anionic emulsifiers are used, the stability and efficacy of the composition is not affected below said pH limitations.
Additionally, the usual elements of a modern sunscreen emulsion system, such as a polymeric thickener/stabilizer, one or more additional emollient oils, microbial preservatives, waterproofing agents, antioxidants, fragrance, humectant, and of course the water vehicle are utilized without known selection or restraint.
The base formulation of the compositions of this invention may also be used as carrier compositions for 15 active topical agents having dermatological effects, including depigmentation agents, anti-aging ingredients, antifungal agents, antimicrobial agents, insect repellents and the like. For example, depigmentation agents can include magnesium ascorbyl phosphate or hydroquinone. Anti-aging agents can include retinoid compounds and alpha-hydroxy acids. Antifungal agents which can be included in the compositions of this invention include azole compounds including ketoconazole 10 and the like. Antimicrobial agents can include triclosan. Insect repellent fragrances can be included 9 in the compositions of this invention. Other products known to those of ordinary skill in the art may be delivered to the skin using the compositions of this 15 invention. The compositions of this invention would then have dual-action capability, as they would contain both sunscreen agents and other actives for protecting *o and/or treating the skin.
The compositions of this invention can be 20 incorporated into various cosmetic and personal care S" products such as hand and body lotions, oils, ointments, lip balm products, facial cosmetics and the like.
The sunscreen compositions of this invention may be prepared using one of at least two methods: a twovessel method, in which the oil and water phases are individually prepared, and a one- vessel method into which all ingredients are added in selected, specific order. Any of these processes will produce a smooth, uniform, white to light ivory emulsion.
In accordance with the two-vessel process, a water phase is prepared by measuring deionized water into a 16 beaker and mixing. The elements of the water phase, including emulsifiers and humectants, chelators, thickeners, waterproofing agents, neutralizing agents and antioxidants should be added and the solution heated. The anionic emulsifier may be placed into the water phase or into the oil phase, depending upon the nature of the emulsifier. The oil phase is prepared separately in another vessel, including the anionic emulsifier, carrier oil, emollient and inorganic sunscreen agent. The two phases are then held at a relatively high temperature and mixed.
More specifically, in the two-vessel process, the water phase is prepared by measuring deionized water into a beaker and mixing. Next, Carbopol 940 (available S. 15 from B.F. Goodrich of Cincinnati, Ohio) should be added and the composition mixed until properly hydrated.
Propylene glycol and EDTA should then be added and the composition mixed until a homogeneous solution is achieved. The solution should then be heated to 70-80 0
C.
0 20 The solution should be maintained at 70-80 0 C for phasing.
The oil phase is then prepared by adding the following ingredients into a beaker: BHT, Velsan D8P3 (available from Clariant Corporation, Charlotte, North Carolina), Stearic Acid, Cetyl Alcohol and Miglyol 812 (available from Huls Company of Piscataway, New Jersey).
The beaker should be placed in a water bath on an electric hot plate. The ingredients sh' .ld be heated to about 80 0 C or until melted. The titanium dioxide should be added slowly and the composition stirred at high 17 speed until homogeneous. The mixture should be maintained at about 80 0 C until phasing.
The composition may then be phased by adding the Oil Phase to the Aqueous Phase and mixing, holding the temperature at about 80°C for 5 minutes. Sodium hydroxide should then be added (as a 10% solution) and the composition mixed for 5 minutes at high speed.
Next, the.mixing speed should be reduced and cooling begun. When the temperature of the batch reaches 45°C, Dowicil 200 (a 33% solution of Quaternium available from Dow Chemical Company, Dearborn, MI) is added and, optionally, fragrance. The pH should be checked and adjusted to a value above pH 5.0 with a solution of Sodium Hydroxide, if needed. Deionized 15 water may be added as required to bring the batch to final weight. When the temperature of the batch reaches 28-32°C, mixing and cooling may be discontinued.
In the one-vessel process, the water and oil phases may be made in the same vessel, provided that the components are added in an appropriate order. For example, the water phase should be created first, adding water and optionally certain emulsifiers which are compatible with the water phase to the vessel. The vessel should be heated to about 85 0 C to about 95 0
C.
Once the temperature reaches this level, the oil phase components may be added, including, optionally, the anionic emulsifier if it is oil-phase compatible and the carrier oil, as well as any additional oil-phase emulsifiers, antioxidants and emollients that may be desired. The temperature should be maintained at this 18 level for about 15 minutes, and the inorganic sunscreen agent added slowly, and the composition mixed for a period of time of at least about 30 minutes. After cooling the pH may then be checked and adjusted if needed, Dowicil, a preservative added as well as optional fragrance.
More specifically, deionized water may be added to e a beaker to which is slowly added Carbopol 940. Next, EDTA is added and the composition mixed at high speed 10 for 15-20 minutes or until the Carbopol is properly hydrated. Heating of the mixture to 92-95C should-be begun and the required amount of Propylene Glycol added during this time. When the temperature reaches 92-95 0
C,
BHT, Velsan D8P3, Stearic Acid, Cetyl Alcohol and see"* 15 Miglyol 812 are added. The temperature of the mixture should be maintained at about 92-95C for about minutes. Then, titanium dioxide should be added and the composition mixed for 30 minutes. Sodium Hydroxide (as a 10% solution) should be added and the composition *s 20 mixed for 30 minutes at 88-92°C. The composition should be cooled and, at 40 0 C, Dowicil 200 solution added as well as optional fragrance. The pH should be adjusted to above pH 5.0 with Sodium Hydroxide. Finally, sufficient water should be added to bring the batch to the target weight.
The following examples serve as illustrations of the compositions of this invention, however, they do not limit the scope of the invention described herein.
19 Example 1 743.07 ml deionized water was added to a beaker.
grams Carbopol 940 (available from B.F. Goodrich of Cincinnati, Ohio) was then slowly added to the beaker.
gram Disodium EDTA was then added and the composition mixed at high speed for 15-20 minutes or until the Carbopol was properly hydrated. The mixture was heated to 92-95°C and 30 grams of propylene glycol 10 was added. When the temperature reached 92-95°C, 0.5 g BHT, 25 grams Velsan D8P3 (available from Clariant Corporation, Charlotte, NC), 50 grams stearic acid, grams cetyl alcohol and 37.5 grams Miglyol 812 (available from Huls Company of Piscataway, New Jersey) were added. 45 grams titanium dioxide MT-100T (an aluminum stearate coated microfine titanium dioxide available from Tri-K Industries, Emerson, NJ), was then added to the vessel and the composition mixed for minutes at 88-92°C. Cooling began and, when the composition reached 40 0 C, 3 grams Dowicil 200 (a 33% solution of Quaternium 15) was added, as well as :grams of fragrance. The pH was adjusted to 8 8.5 with 49.93 grams of 10% solution of sodium hydroxide (target pH is 8.25). Finally, sufficient deionized water was added to bring the batch to the target weight.
The in-vitro SPF (Sun Protection Factor) of this composition was measured using the system described by Cole and VanFossen [Cole, VanFossen (1990) In-vitro model for UVB and UVA protection. In: Sunscreens: Development, Evaluation and Regulatory Aspects, N. Shaath and N. Lowe Eds., Marcel Dekker Pub.
20 New York, Briefly, this system consists of the measurement of transmission of solar simulated UV radiation through composition (2.0 mg/cm 2 applied to the substrate, Transpose T tape in this instance. The system consists of an optical sensor that is only sensitive to sunburning radiation and has a sensitivity spectrum similar to the human erythema sensitivity spectrum. The SPF is the ratio of the optical signal through the substrate without sunscreen divided by the optical signal through the substrate coated with the sunscreen.
The system is calibrated against a series of sunscreens of known SPF (4 through 36) determined in-vivo using the FDA monograph method (Federal Register, Aug. 25, 1978, Sunscreen drug products for over-the-counter human 15 drugs. pp 38206-38269.) The resulting SPF of the composition of Example I above is 16.9 and the composition is aesthetically satisfactory and stable.
Examples 2-13 V In the next series of examples the use of titanium .i* dioxides of different origins and/or types of coating at the same concentration of 4.5% was investigated. The compositions were all made in accordance with the method set forth in Example 1, having the same components in the same concentrations but for the varied component.
The results are set forth in Table I.
21 TABLE I S. Effect of T.0 2 Coating on the SPF TiO 2 7110 2 Source Surface Treatment SPF MT-lOOT "Al, Stearic Acid 16.9 (Tri-K Industies, Inc.) MT-SOOB None 13.6 (Tri-K Industries. Inc.) 9.9 SMT-lO0SAS Methyl hydrogen polysiloxane (Tni-K Industries, Inc.) UV Titan M262 Alumina, Dimethicone 18.0 (Presperse. Inc.) 12.0 UV Titan M212 Alumina, Glycerin (Prespersr, Inc.) P25 None 9.1 (Degusa)_ STT65C-S None 12.1 (Kobo) DMI40 KSI STr65C-S surface Uraicd with 11.5 (Kobo) silicone STr-30D-S Al, Si, Silicone 3.8 (Kobo) (11) SIT-30S-L AL Steanic Acid 7.3 M~OWo_ (12) TiO 2 (Hydrophobic) Methicone, Dimethicone 12.0 (Creative Polymers)_____ (13) TiO 2 (Hydrophilic) Dimethicone Copolyol 7.7 (Creative Polymers) 22 Examples 14-17 In this series of examples, the concentration of titanium dioxide was varied and the resulting SPF was measured. The formulae are made in accordance with the method set forth in Example 1 and differ in concentration only as to the amount of titanium dioxide.
The difference was made up with deionized water.
10 MT-100T Titanium dioxide
SPF
concentration S (14) 4.5% 17.1 (15) 6.0% 25.3 (16) 7.5% 20.4 (17) 15.0% 43.1 Examples 18-38 The following examples are intended to show which 20 anionic emulsifiers result in a high SPF. The compositions were identical to that of Example 1, except in that the anionic emulsifier was varied in accordance with the information set forth in Table II below. From the data presented in the Table II, it can be seen that dioctyl sodium sulfosuccinate, DEA cetyl phosphate (Amphisol) under the right circumstances, Sodium lauryl sulfate and Sodium stearate are all effective in yielding an SPF higher than 23 TABLE i i Effect of Anionic Emulsifiers on the SPF
SPF
(18) Sodium Stearate (NaOH NeuL)- Stearic acid plus Sodium Hydroxidc 11.6 (19) Sol1um, Stcarate in water pha&e 15.7 5.0a Isostearic Acid no Brij 72 1, no Stearic Acid w.ith Miglyol 8 12 and Velsan D8P3 (21) 5.05/ Isostcaric Acid (added to H 2 0 NaOH) 3.0% Brij 721 8.6 (22) Oleic Acid, no Steaic Acid, pH adj. 6.1. 5.2 (23) Lauric Acid, no Steaic Acid 6.4 (24) 2.0% Amphisol with 3.0%Y Brij 721 and Stearic Acid, no pH adj. 12.3 2.09% Amphisol with Brij 721 and no Steatic Acid .8.1 (26) 2.0% Amphisol with Brij 721 and Beftwx. no Stearic Acid, no pH adj. 15.1 (27) 0.5% Sodium Lauryl Sulfate with Steauric Acid, 3.OY.* Brij 721, no pH 4d. 15.0 (28) Avancl SI150 Miglyol 8 12 Stcaric acid (5.06K), no pH adj. 5.1 (2.3) (29) Avanel Si150 Steanic Acid Velsan D8P3 Miglyol 8 12 3.2 Brij 721 (3%1 (30):Av.an1 S 150 VeLsan D9P3 Migyol 8 12 7.0 (2.6) (31) 2.7%A Brij 721, 0.3% Brij 72 and 0. 5% Rewodcrm S 133 3. no Steaic Acid, pH--7 4.1 (32) 2.7%A Tee 60,0.3% Span 60 and 0.5% Rewoderm S1333. no Steatic Acid, 4.2 PH-7 (33) 3.00A Gluce= E-20 Distearate and 0.5% Rewodetm S 1333, no Stearic Acid, 3.8 pH-7 (34) 3.0% Gluca SSE.20, 0.5% Rewodctn S1333, no Staic Acid, pH-7 1 .01/ Lecithin. no Steatic Acid 3.0% Brij 72 1, no pH adj.
.24 a. a a a a.
a a a a a (36) Aerosol OT-75 vih .3teaic Acid, Brij 721, no pH adj. 11.2 (37) Aerosol OT-75 with Steai-ic Acid, Brij 721, 0.5% Sodium Stearate, no pH adj. 16.2 (38) Haniposvl C-30, no Stearic acid 5.9 The brand names set forth above refer to the following compounds: Brij 721, Non ionic suractant P~iyoxyethyiene 21 stearyl ether Mfiglyol 812: Capric/caprylic triglyccaidc Velsan DgP3: PPG-2 isodec th-7 earhoxylate Rewoderm S-1 333: Disodium Ticinoleamido MEA sulfosugccinaz Amphisol: DE-A Cetyl phosphate Aerosol OT-75: Dioctyl sodium sulfosuccinate Hamposyl is a sodium cocoylsarcosinate, an anionic =nuisifier Examples 39-4 6 The following examples 39-46 demonstrate that nonionic emulsifiers by themselves do not result in a 15 high SPF. The compositions set forth below are identical to that of Example 1 except for the variations indicated in Table III below.
T.AME III a a.
a a a .a a a a Effect of Non ionic Eminufler on the SPF
SPF
(39) 6.0% Cetyl Alcohol, no Stearic Acid 3.0% Brij 72 1, and no pH adj. 2.7 5.0% Glyceayl Moositazui, 2.0% Tween 60, 1.0% Aulacel 60. no 2.9 Stearic Acid, p11=7 (41) 5.0% Glyceryl Monostearu, 3.0% Bhij 721. no Stewic Acid 5.1 (42) 2.7% Brij 721/ 0.3% Brij 72, na Staic Acid, pH-7 (43) 2.7% Tween 60, 0.3% Span 60, no Stearic Acid, pH-7 3.6 (44) 3.0% Glucam E-20 Disiemyate, no Stearic Acid 2.9 25 3.0% Gluran SSE-20. no Steanic Acid 3.
(46) 5.01/ Glucamn P-20. no Stwaic Acid Tee 60 is a polyxythylene (20) sorbitan monosteanlec.
Arlacel 60 is a sorbitan monostearatc.
Arlacel 165 is a glycerol monosteaae and polyoxyeihylene stcmar Span 60 is a sorbitan monostaai.
Glucam E-20 disiarate is a methylgluceth 20 disturatc.
Glu-am SSE-20 is an ethoxylated (20) methyl glucoside sequistearnte.
Examples 47-90 The following Examples 47-90 set forth the importance of using carrier oils in the products of this invention in conjunction with emollient oils known to 15 those of ordinary skill in the art and available commercially. They are similar to Example 1, varying only the oil component, as indicated below.
9* .9 9* 99 9.
9 9
U
9* *99* 9* a 9 TABLE IV Effect of Single Oils and Oil asliume Finsolv TN (48) Fmnaolv TN (2.5%)kMiglyol 812 15.9 (49) Finsolv TN (3.7S%yVelsan DSP3(2.S%) 16.4 18.4 (4.4) Finsolv TN (3.125%y Mineral Oil NF (3.125%) 9.1 (3.2) (5S1) Fmnsolv TN (3.12.5%yCetiol 868 (3.125%) 8.2 (2.9) (52) Miglyol 812(6.2.5%) 8.9 (3.2) (53) Velsan DM (6.25%) 10-00.3) -26 S. *e S S.
S
*S
S.
*5
S
S
S
S
S (54) Procetyl AWS 9.9 (3.4) Procctyl AWS (3.75%yVelsan DSP3 16.8 (4.2) (56) Procetyl AWS (3.7S%)Mglyal 812 10.6 (3.3) (57) Procry'1 AWS 125%YMineal Oil NF (3.125%) 10.7 (3.2) (58) Procetvl AWS (3.125%yCitinol 316 (3.125%) 1 (59) sopropyl Myrimxtc(6.25%) 8.7 5.2 j2.4) (60) Isopropyl Myristate(3.75%yfVelsan DSP3 13.0 (3.4) (61) Cetiol 868 8.7 (62) Cetiol 968 (3.75%yVelsan D8P3 14.2 (3.7) (63) Mineral Oil, NF(6.25%) 6.7 (2.9) (64) Mineral Oil, NF (3.75%y(Velsan D8P3 15.2 (3.8) Minal Oil, NF 125%YICitio1 316 (3.125%) 4.3 (2.4) (66) Mineral Oil, NF (3.125%YMizmo 21 (3.125%) 4.6 (2.1) (67) Drakeol-7 (2.5%YMglyoI 812 6.9 f2.9) (68) Kicarl 11.0 (3.4) (69) Kicarol (2.S%)Mglyol 812 6.6 Artamol E 5.3 (2.2) (71) ArImmol E (3.75%yVe~saz DSP3 14.3 (3.4) (72) Dimethicone 7.3 (73) Dimethicane (3.75%Vclumn DSP3 14.1 (3.7) (74) Dimethicone (2.5%yMglyol 812 3.5 Miglyol 812 (3.0%/YVeLsan D8P3 15.1
SS
S.
S
*5 S
S
S
Ewulgin L (2.5%YIMiglyol 812 (3.75%)1182) 11.8(2.9) 27
S
*5 (76) Eumulgin L (6.25%AMig!)yoI 812(3.75%) 11.2 (3.6) (77) Crodamol ML (2.5%yMiglyal 812 10.4 (78) Hetester PHA (2.5%yMiglyol 812 13.1(3.4) (79) Pracety 10 (2.5%YMiglyoI 812(3.75%) 9.5 Marlox FK86 (2.5%Miglyol 812 11.0 (81) Ucon 50 HB-660 (2.5%YMiglyol 812 9.4 (2.8) (82) Etnul m B-2 (2.S%YMiglyol 812 12.5 (3.2) (83) Eumulgin B-2 9.3 (84) Sandoxylate 424 (2.5%yMiglyol 812 13.0 (3.4) (85) Sandoxylate 418 (2.S%YMiglyoi 812 12.8 (3.1) (86) Sandoxylate 412 (2.5%)Mig1yoI 812 16.0 (3.3) (87) Sandoxylate 408 (2.5%Mig1yol 812 15.1 (3.3) (88) UCON 50 HB-660 (2.5%YMiglyol 812 9.4 (2.8) (89) Vehsan P93 (2.5%YMiglyol 812 11.0 Miglyol 812 (3.Wo(Vcsan D8P3 15.1(3.5) 'Values in parentheses indicate protection factors in the UVA region of the spectrum.
2 Multiple data indicate multiple independent formulation trials The brand names set forth above refer to the following commercially available compounds: Eumulgin L: PPG-1-PEG-9 lauryl glycol ether Hetester PHA: PG isoceteth-3-acetate Sandoxylates: PPG-2 isodeceth (4 to 12) Eumulgin B2: Procetyl AWS: PPG-2 28 Cetiol 868: Octyl stearate Citmol 316: Triisocetyl citrate Minno 21: Neopentyl glycol dioctarioate (and) neoperityl glycol Drakeol-7: Mineral oil Klearol: Mineral oil Arlamol E: PPG-15 stearyl ether Crodamol ML: Myristyl lactate Procetyl 10: PPG-10 cetyl, ether Marlox FK86: PPG-8 deceth-6 ~*Ucon 50 HB-660: PPG-12 buteth-16 Avanel S150: Sodium C1 2 15 pareth-15 sulfonate Velsan P8-3: Isopropyl C1-1 pareth-9 carboxylate, Examples 91-94 In the following examples 91-94, the type of Velsan material was varied. Otherwise, the compositions are identical to that of Example 1.
TABLE V Effect of Velsn Type* on the SPF (wi~th Constant Miglyol 8 12 at 3.75%) SPF'2 (9 1) Velsan DSP3 15.3 (3.3) 21.0 (4.2) (92) Velsan D8P16 (paste) 12.6 (93) Velsan D8P16 (liquid) 14.0(3.4) 29 (94) Velsan P8-3 (liquid) 14.0 Velsan level was Values in parentheses indicate protection factors in the UVA region of the spectrum.
2 Multiple data indicate multiple independent formulation trials.
The brand names set forth above refer to the following commercially available compounds: 1 0 Velsan D8P16: Cetyl PPG-2 isodeceth-7 carboxylate Velsan P8-3: Isopropyl C2-i pareth-9 carboxylate Example S 15 A composition for use as a sunscreen was made, having components identical to those of Example 1, but in the oil phase was added 3% of octylmethoxycinnamate and the water adjusted down The resulting composition had an SPF of 23.3. Thus, it can be seen 20 that the compositions of this invention may include organic as well as inorganic sunscreen agents.
Example 96 A composition for use as a sunscreen was made, having components identical to those of Example 1, 5% of zinc oxide and 3% of Brij 721 were added. The resulting composition had an SPF of 20.4 with regard to UVB. The pH of the composition was adjusted to 7. This 30 composit.'n has a significantly enhanced protection value in UVB.
Example 97 A composition for use as a sunscreen having antiaging'properties was made as follows. The formulation of this Example 97 contains the following ingredients: 10 Base formula with Retinol WATER PHASE
W/W%
Deionized Water 74.50 Carbopol 940 0.25 Propylene Glycol 3.00 Citric Acid 0.10 Sodium Stearate 0.50 Dowicil 200 0.10 OIL PHASE :BHT 0.05 Velsan D8P3 2.50 Stearic Acid 5.00 Cetyl Alcohol 1.00 Miglyol 812 3.75 Retinol (10% in Soybean Oil) 1.65 Tocopherol Acetate 0.10 Titanium Dioxide 4.50 Brij 721 3.00 The formulation of this Example was prepared as follows.
The water phase was prepared by measuring formula 31 weight of water into suitable vessel. Carbopol 940 was slowly introduced while mixing to allow the Carbopol 940 to become hydrated. Propylene glycol was then added followed by the sodium stearate and citric acid and the phase mixed for 30 minutes. The mixture was then heated to 90°C. All oil phase ingredients were then combined separately with the exception of the retinol and were well mixed and then heated to 90 0 C. Under yellow light, Retinol was then added to the oil phase 10 which was then added to the water phase and the system cooled while being mixed. Dowicil 200 was then added Swhen the product reached 40°C. The entire mixture was then homogenized on a rotor-stator homogenizer for three minutes. The pH was then adjusted with sodium hydroxide 15 to pH 6.42. The resulting product was then filled into aluminum tubes and purged with argon gas. The product may then be stored.
Example 98 Comparative Example The following composition 98A contained both inorganic and organic sunscreen agents. Composition 98B was made using the same formulation, but the organic sunscreen ingredients were removed. The formulations are as follows: 32 98A 98B Component W/w
W/W
Deionized Water 57.89 60.15 Carbopo. 940 0.40 0.40 Propylene Glycol 3.00 3.0 -0 Disodjum EDTA 0.10 0.10 Carboset XL-19-X2 7.50 7.50 Ammoniacal, solution 2. 60' 2.60 Aerosol OT 0.01 Vitamin E Acetate 0.10 0.10 .Isopropyl. Isostearate 2.50 250 Butylated Hydroxytoluene 0.05 0.05 Finsolv TN 5.00 5.00 .Velsan D8P3 2.50 2.50 Dimethi cone 0.50 0.50 Isostearic Acid 20 0 2.00 Cetyl Alcohol 1.00 1.00 Amphisol 2.00 2.00 .44Oxybenzone 2.75 *Parsol MCX 6.50 Hombifine S-35 (T1O 2 1.00 3.96 Octyl Salicylate 1.00 Lexamul GDL 1.00 1.00 Dowicil 200 (33% Solution) 0.30 0.30 Fragrance 0.30 0.30 Mineral Oil 2.52 Isopropyl Myristate 2.52
SPF
SP20.2 2.4 33 As demonstrated by the foregoing SPF values, Formulation 98B, which did not contain any organic sunscreen agents, had an extremely low sun protection factor and was quite inefficient in its utilization of titanium dioxide.
Thus, merely removing the organic sunscreen agents from Formulation 98A did not result in comparable SPF values.
Example 99 Comparative Example S In this example, Formulation 99A contained isostearic acid, a branched-chain anionic emulsifier.
Formulation 99B contained stearic acid, a straight-chain anionic emulsifier in accordance with the products of 15 this invention. The formulations were as follows: 99A 99B Component W/W W/W Deionized Water 80.95 80.95 Carpobol 940 0.40 0.40 Propylene Glycol 3.00 3.00 Disodium EDTA 0.10 0.10 Vitamin E Acetate 0.10 0.10 Butylated Hydroxytoluene 0.05 0.05 Velsan D8P3 2.50 2.50 Isostearic Acid 5.00 Stearic Acid 5.00 Cetyl Alcohol 1.00 1.00 Micro TiO2 SA-20 4.00 4.00 Dowicil 200 (33% Sol'n) 0.30 0.30 Fragrance 0.30 0.30 34 D&C Red #33 Sol'n) 0.90 0.30 Sodium Hydroxide (50% Sol'n) 1.40 1.40 SPF 7.1 21.2 It can be seen that Formulation 99B, which contained stearic acid, a straight-chain anionic emulsifier in accordance with this invention, resulted in a considerably higher SPF than that of Formulation 99A, 10 which contained isostearic acid, a branched-chain anionic emulsifier.
Example 100 15 A sunscreen composition suitable for use as a dualaction carrier formulation was made containing the fellowing materials: Component CTFA Name
%W/W
Deionized Water 78.15 Glycerin 99% 3.00 Carbopol 940 0.25 Disodium Edetate 0.10 Acetamide AMEA 2.50 Velsan D8P3 2.50 Stearic Acid 4.00 Caprylic/Capric Triglyceride 3.75 Titanium Dioxide 4.50 Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate 1.00 Bisabolol 0.20 35 Butylated Hydroxytoluene 0.05 Sodium Hydroxide Adjust pH to The formulation of this Example 100 may be prepared as follows. The water phase was prepared by measuring formula weight of water into suitable vessel. Carbomer was slowly introduced while mixing to allow the Carbomer to become hydrated. The EDTA was then added, and the phase mixed for 30 minutes. After 30 minutes, the 10 mixture was heated to 90C. Glycerin and AMEA were then added to the phase. The BHT, Velsan D8P3, Stearic Acid, Cetearyl Alcohol and Caprylic/Capric Triglyceride and.
Bisabolol were then added. The temperature was held at 90 "C for fifteen minutes. The Titanium Dioxide was 15 slowly added and the composition mixed for 30 minutes.
The Sodium Hydroxide was added in solution form in order to adjust the pH to between 7 and 7.5. The solution was then mixed for 30 minutes at 88-920 C, forming the emulsion. The composition was then cooled to 350 C and 20 the pH again adjusted. Deionized water Was then added to replace evaporative loss and the batch homogenized for 5 minutes.
Additional formulations may be made in accordance' with the process set forth in this Example 100 in order to create compositions according to this invention which contain one or more active ingredients in addition to the sunscreen. The carrier base of this invention affords a spreadable, cosmetically elegant composition in which to apply both sunscreen agents and additional topical active materials, as set forth below.
36 The following formulations may be produced according to the procedure set forth above in Example 100 with the understanding that the process may be adjusted to suit the specific materials. Adjustments may include, but are not limited to, pH of the final product, order of addition of raw materials and/or processing temperatures as necessary.
Example 100A Dihydroxyacetone-containing (sunless 10 tanning) composition: 9 Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Acetamide AMEA Velsan D9P3 Stearic Acid 20 Caprylic/Capric Triglyceride Dihydroxyacetone Titanium Dioxide MT 100T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj w/w 74.15 3.00 0.25 0.10 2.50 2.50 4.00 3.75 4.00 4.50 1.00 0.20 0.05 ust pH to Example 100B Composition containing a skin whitening agent, Magnesium Ascorbyl Phosphate: 37 a. a Commonent CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Mag. Ascorbyl Phosphate Acetamide AME-A Velsan D8P3 10 Stearic Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 100T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate 15 Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj
W/W
75.15 3.00 0.25 0.10 3.00 2.50 2.50 4.00 3.75 4.50 1.00 0.20 0.05 ust pH to Example 100C Composition containing a skin whitening 20 agent, Hydroquinone: Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Hydroquinone Acetamide AMEA Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride
W/W
76.15 3.00 0.25 0.10 2.00 2.50 2.50 4.00 3.75 38 Titaniumn Dioxide MT 100T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj 4.50 1.00 0.20 0.05 ust PH to Example 1OOD: Composition containing oil soluble Retinoic Acid: COm)onent CTFA Name Deionized Water Glycerin 99% Carbopol 940 15 Disodium Edetate Acetamide
AMEEA
Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride 20 Titanium Dioxide MT l00T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Retinoic Acid Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adji
W/W
78.14 3.00 0.25 0.10 2.50 2.50 4.00 3.75 4.50 1.00 0.01 0.20 0.05 ast pH to 39 Example 100E: Composition containing oil-soluble Retinaldehyde: a a a.
a a a a a. a Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium, Edetate Acetamide AMEA 10 Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 100T Cetearyl Alcohol, Sodium Cetearyl 15 Sulfate and Sodium Sulfate Retinaldehyde Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj W/w 78.07 3.00 0.25 0.10 2.50 2.50 4.00 3.75 4.50 1.00 0.08 0.20 0.05 ust pH to Example 10OF: Composition containing oil Retinol: soluble Component CTFA.Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Acetamide AMEA Velsan D8P3 Stearic Acid W/w '78.07 3.00 0.25 0.10 2.50 2.50 4.00 40 Caprylic/Capric Triglyceride Titanium Dioxide MT 10OT Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Retinol- Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adja 3.75 4.50 1.00 0.08 0.20 0.05 1St. PH to S.
S
S. Examiple 1boG: Composition containing oil-solujble Retinyl Palmitate: Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Acetamide
AMEA
2.0 Velsan D8P3 Stearic Acid Cap rylic/Capric Triglyceride Titanium Dioxide MT 1OOT Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Retinyl Palmitate B is abo 101 Butylated Hydroxytoluene Sodium Hydroxide Adj W/w 77.35 3.00 0.25 0.10 2.50 2.50 4.00 3.75 4.50 1 .00 0.80 0.20 0.05 ust pH to i1 Example 100H: Composition c,3ntaining an antifungal agent: 9 @9 9 *9 9* 9 9*9 *9 9.
Component CTFA Name Deionized Water Glycerin 99% Carbo'pol 940 Disodjum-Edetate Acetamide PIMF.A 10 Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 100T Ceteary. Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Ketoconazole Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj
W/W
76.15 3 .00 0.25 0.10 2.50 2.50 4.00 3.75 4.50 1.00 2.00 0.20 0.05 ust pH to *9 9 .9 9. 9.
9 9 0 .9 .9 Example 100J: Composition containing an antimicrobial agent: Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edetate Acetamide
AMEA
Velsan D8P3
W/W
77.65 3.00 0.25 0.10 2.50 2.50 42 Stzaric Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 100T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Tri'closan Bisabolol Butylated Hydroxytoluene Sodium Hydroxide -Adji 4.00 3.75 4.50 1.00 0.50 0.20 0.05 ast pH to Examiple 10OK: Composition containing an "insect repellent" fragrance: Component CTFA Name Deionized Water Glycerin 99% Carbopol 940 Disodium Edatate Acetamide
AMEA
20 Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 1O0T Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Insect Repellent Fragrance Bisabolol Butylated Hydroxytoluene Sodium Hydroxide Adj
W/W
72.15 3.00 0.25 0.10 2.50 2.50 4.00 3.75 4.50 1.00 6.00 0.20 0.05 ust pH to 43 Example 10OL: Composition containing iron oxides: 6e 0 *0 0 0 00 0 0 0 00 0 0 0 Component CTFA Name Deionized Water Glycerin 99% Veeqwn Disodium .Edetate Acetamide AMF.A 10 Velsan D8P3 Stearic Acid Caprylic/Capric Triglyceride Titanium Dioxide MT 100T Iron Oxide Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate Keltrol Bisabolol Butylated. Hydroxytoluene 20 Sodium Hydroxide Adj
W/W
76.49 3.00 0.60 0.10 2 2 4 .00 3 4 1 .66 1.00 0.40 0.20 0.05 ust pH to Example 10OM: Composition containing an Alpha Hydroxy Acid: Component CTFA Name Deionized Water Carbopol 940 Disodium Edetate Sodium Stearate Propylene Glycol Butylated Hydroxytoluene W/w 55 0.25 0 5.00 3.00 0.05 44 Velsai D8P3 2.50 BRIJ 721 3.00 Cetearyl Alcohol, Sodium Cetearyl Sulfate and Sodium Sulfate 1.00 Caprylic/Capric Triglyceride 3.75 Stearic Acid 5.00 Titanium Dioxide MT lOOT 4.50 Glycolic Acid (70% solution) 7.14 .Sodium Hydroxide (20% solution) 8.66 10 Dowicil 200 0.10 The pH of this product should be adjusted to about 5.15.
Claims (18)
1. A sunscreen composition comprising: an inorganic sunscreen agent; an anionic emulsifier selected from the group consisting of salts of saturated fatty acids, salts of straight-chain fatty acids, alkyl sulfosuccinates, alkyl phosphates and mixtures thereof; and an oil component comprising a carrier oil and at least one emollient.
2. A sunscreen composition according to claim 1 wherein said inorganic sunscreen agent is selected from the group consisting of titanium dioxide, zinc oxide and mixtures 10 thereof.
3. A sunscreen composition according to claim 2 wherein said inorganic sunscreen agent is titanium dioxide.
4. A sunscreen composition according to claim 3 wherein said titanium dioxide has a primary particle size of less than about 300 nanometers.
5. A sunscreen composition according to claim 1 wherein said anionic emulsifier is a salt-of a fatty acid.
6. A sunscreen composition according to claim 1 wherein said anionic emulsifier is selected from the group of sodium stearate, sodium lauryl sulfate, DEA cetyl phosphate, and dioctyl sodium sulfosuccinate.
7. A sunscreen composition according to claim 1 wherein said carrier oil is selected from the group consisting of benzoic acid fatty alcohol esters, 46 polyalkoxylated fatty substances of the general formula R-Ox -Poy -EOz wherein x=l, 2 or 3, y=0 to 4, z= 6 to with R=Cs to C5, and polyether interrupted fatty acid esters.
8. A sunscreen composition according tu claim 7 wherein said polyether interrupted fatty acid ester is a Ce to C 2 2 fatty alkyl (optionally polypropylenoxy) polyethylenoxy carboxylate ester, the ester having an alkyl group which has from one to twenty-two carbon 10 atoms, optionally straight or branched.
9. A sunscreen composition according'to claim 7 wherein said carrier oil is a benzoic acid fatty alcohol ester.
10. A sunscreen composition according to claim 7 15 wherein said carrier oil is a.polyalkoxylated fatty substances of the general formula R-O -Poy -EO, wherein x=l, 2 or 3, y=0 to 4, z= 6 to 20 with R=C@ to Cs.
11. A sunscreen composition according to claim I wherein said composition further comprises nonionic 20 emulsifiers or mixtures thereof.
12. A sunscreen composition according to claim 1 wherein said composition has a pH of at least
13. A sunscreen composition according to claim 12 wherein said pH is from about 7.5 to about
14. A sunscreen composition according to claim 1 having a Sun Protection Factor of at least A method of making a sunscreen composition comprising: adding deionized water to a vessel; then, heating the water; -47- then. adding a carrier oil and an anionic surfactant to the vessel; then, slowly adding an inorganic sunscreen agent to said vessel and heating and mixing said resultant composition; and then. adjusting the pH of said composition to above
16. A sunscreen composition comprising from about 2% to about 25% of an inorganic sunscreen agent, from about 0.01% to about 10% of an anionic surfactant and from about 0.1% to about 10% of an oil component comprising a carrier oil and an emollient.
17. A sunscreen composition according to Claim 1 wherein the ratio of inorganic sunscreen agent to oil component is from about 0.3:1 to about 1:1. 10 18. A sunscreen composition according to Claim 1 wherein said composition further comprises one or more topically active agents. s
19. A sunscreen composition according to Claim 18 wherein said topically active agents are selected from the group consisting of: a sunless tanning agent, an organic sunscreen agent, an antimicrobial agent, a depigmentation agent, an anti-aging agent, an 15 antifungal agent, an insect repellent and a combination thereof. A sunscreen composition substantially as herein described with reference to any one of the examples, but excluding comparative examples.
21. A method of making a sunscreen composition substantially as herein described with reference to any one of the examples, but excluding comparative examples. DATED this 23rd day of August 2000 JOHNSON JOHNSON CONSUMER COMPANIES, INC. Attorney: CHARLES WILLIAM TANSEY Registered Patent Attorney of The Institute of Patent and Trade Mark Attorneys of Australia of BALDWIN SHELSTON WATERS
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU53583/00A AU739377B2 (en) | 1995-06-08 | 2000-08-23 | Sunscreen compositions |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US495734 | 1995-06-08 | ||
| AU53583/00A AU739377B2 (en) | 1995-06-08 | 2000-08-23 | Sunscreen compositions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU65409/96A Division AU6540996A (en) | 1995-06-08 | 1996-06-07 | Sunscreen compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5358300A true AU5358300A (en) | 2000-10-26 |
| AU739377B2 AU739377B2 (en) | 2001-10-11 |
Family
ID=3739607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU53583/00A Ceased AU739377B2 (en) | 1995-06-08 | 2000-08-23 | Sunscreen compositions |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU739377B2 (en) |
-
2000
- 2000-08-23 AU AU53583/00A patent/AU739377B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU739377B2 (en) | 2001-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5980871A (en) | Sunscreen compositions | |
| CA1341147C (en) | Sunscreen compositions | |
| CA2440371C (en) | Skin care emulsion composition comprising an epichlorohydrin crosslinked glyceryl starch | |
| US6540986B2 (en) | Sunscreen compositions | |
| US20050031655A1 (en) | Emulsion composition | |
| EP0433086A1 (en) | Sunscreen compositions | |
| US6858200B2 (en) | Sunscreen formulations | |
| JP2015155474A (en) | Skincare compositions | |
| CN1430500A (en) | Skin care moisturizing and sunscreen compositions comprising organic particulate material | |
| US20060233725A1 (en) | Non-Endocrine Disrupting Cytoprotective UV Radiation Resistant Substance | |
| JPH08268839A (en) | Zinc oxide-coated extender pigment and cosmetics containing it | |
| AU739377B2 (en) | Sunscreen compositions | |
| MXPA97009889A (en) | So filter compositions | |
| SA96170270B1 (en) | Sunscreen formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |